Your account is not claimed yet. You can sign up with ORCID to claim your account.

Katherine L B Borden (Katherine Lb Borden, Klb Borden)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Venues

BioEssays : news and reviews in molecular, cellular and developmental biology

The EMBO journal

Cancer research

Biochemical Society transactions

This page only lists publications with an associated author ORCID identifier.

Publications

Rossella Marullo, Sarah C Rutherford, Maria Victoria Revuelta, Nahuel Zamponi, Biljana Culijkovic, Nikita Kotlov, Nicolás Di Siervi, Juan Lara-Garcia, John N Allan, Jia Ruan, Richard R Furman, Zhengming Chen, Tsiporah B Shore, Adrienne A Phillips, Sebastian Mayer, Jingmei Hsu, Koen van Besien, John P Leonard, Katherine L B Borden, Giorgio Ga Inghirami, Peter Martin, Leandro Cerchietti
XPO1 enables adaptive regulation of mRNA export required for genotoxic stress tolerance in cancer cells. Cancer research (2023)
Katherine L B Borden
The eukaryotic translation initiation factor eIF4E unexpectedly acts in splicing thereby coupling mRNA processing with translation: eIF4E induces widescale splicing reprogramming providing system-wide connectivity between splicing, nuclear mRNA export and translation. BioEssays : news and reviews in molecular, cellular and developmental biology (2023)
Mehdi Ghram, Gavin Morris, Biljana Culijkovic, Jean-Clement Mars, Patrick Gendron, Lucy Skrabanek, Maria Victoria Revuelta, Leandro Cerchietti, Monica L Guzman, Katherine L B Borden
The eukaryotic translation initiation factor eIF4E reprograms alternative splicing. The EMBO journal (2023)
Katherine L B Borden
Cancer cells hijack RNA processing to rewrite the message. Biochemical Society transactions 50 (5) (2022)
Katherine L B Borden
The search for genetic dark matter and lessons learned from the journey. Biochemistry and cell biology = Biochimie et biologie cellulaire 100 (4) (2022)
Katherine L B Borden, B Culjkovic-Kraljacic, V H Cowling
To cap it all off, again: dynamic capping and recapping of coding and non-coding RNAs to control transcript fate and biological activity. Cell cycle (Georgetown, Tex.) 20 (14) (2021)
Katherine L B Borden, Laurent Volpon
The diversity, plasticity, and adaptability of cap-dependent translation initiation and the associated machinery. RNA biology 17 (9) (2020)
Hiba Ahmad Zahreddine, Biljana Culjkovic-Kraljacic, Jadwiga Gasiorek, Jean Duchaine, Katherine L B Borden
GLI1-Inducible Glucuronidation Targets a Broad Spectrum of Drugs. ACS chemical biology 14 (3) (2019)
Hiba Ahmad Zahreddine, Biljana Culjkovic-Kraljacic, Audrey Emond, Filippa Pettersson, Ronald Midura, Mark Lauer, Sonia Del Rincon, Valbona Cali, Sarit Assouline, Wilson H Miller, Vincent Hascall, Katherine L B Borden
The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity. eLife 6 (2017)

Katherine L B Borden.css-eqlu8i{font-size:small;padding-left:4px;} (Katherine Lb Borden, Klb Borden)

Publication Activity (10 Years)

Top Topics

Top Venues

Katherine L B Borden (Katherine Lb Borden, Klb Borden)